Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001170918-07-000162

Options or other derivatives

  • Director acquired 7,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Larner Drew Director 2007-02-17 Grant or award · Options to Purchase Common Stock +7,500,000 7,500,000 D: show line 1 in the form
Loading xslF345X02/sam07-043_ex.xml…